CD8A and neoplasm: Taken together, the factorization of scRNA-seq data by MGPfact provides highly relevant gene expression signatures of the fate of tumor-associated CD8+ T cells, which advances the understanding of the evolution of tumor immune microenvironment (TIME) and predicts clinical outcomes.